Chemoinformaics analysis of Methyl 2-(ethylamino)benzoate
| Molecular Weight | 179.219 | nRot | 3 |
| Heavy Atom Molecular Weight | 166.115 | nRig | 7 |
| Exact Molecular Weight | 179.095 | nRing | 1 |
| Solubility: LogS | -2.929 | nHRing | 0 |
| Solubility: LogP | 2.544 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 28.0723 |
| nHD | 1 | BPOL | 16.2157 |
| QED | 0.72 |
| Synth | 1.586 |
| Natural Product Likeliness | -0.783 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.86 |
| HIA | 0.004 |
| CACO-2 | -4.426 |
| MDCK | 0.0000297 |
| BBB | 0.3 |
| PPB | 0.830261 |
| VDSS | 1.052 |
| FU | 0.156388 |
| CYP1A2-inh | 0.979 |
| CYP1A2-sub | 0.946 |
| CYP2c19-inh | 0.765 |
| CYP2c19-sub | 0.707 |
| CYP2c9-inh | 0.269 |
| CYP2c9-sub | 0.772 |
| CYP2d6-inh | 0.085 |
| CYP2d6-sub | 0.796 |
| CYP3a4-inh | 0.207 |
| CYP3a4-sub | 0.162 |
| CL | 9.55 |
| T12 | 0.815 |
| hERG | 0.07 |
| Ames | 0.019 |
| ROA | 0.05 |
| SkinSen | 0.376 |
| Carcinogencity | 0.04 |
| EI | 0.978 |
| Respiratory | 0.64 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.868021 |